Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004198959 | SCV003699900 | uncertain significance | not specified | 2021-09-01 | criteria provided, single submitter | clinical testing | The c.12230C>T (p.S4077F) alteration is located in exon 17 (coding exon 17) of the FSIP2 gene. This alteration results from a C to T substitution at nucleotide position 12230, causing the serine (S) at amino acid position 4077 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003883930 | SCV004698216 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | FSIP2: BP4 |